JP2012072150A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012072150A5 JP2012072150A5 JP2011233155A JP2011233155A JP2012072150A5 JP 2012072150 A5 JP2012072150 A5 JP 2012072150A5 JP 2011233155 A JP2011233155 A JP 2011233155A JP 2011233155 A JP2011233155 A JP 2011233155A JP 2012072150 A5 JP2012072150 A5 JP 2012072150A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- salt
- formulation
- quaternary pyridinium
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (9)
- 式Ｉ：
の四級ピリジニウム塩を含む、哺乳類におけるプロスタサイクリンＰＧＩ ２ レベルを高めるための薬学的製剤。 - 食物補助のためのものである、請求項１に記載の製剤。
- 治療製剤である、請求項１に記載の製剤。
- 四級ピリジニウム塩が１−メチルニコチンアミド塩である、請求項１〜３のいずれか一項に記載の製剤。
- 四級ピリジニウム塩が、１−メチル−Ｎ’−（ヒドロキシメチル）ニコチンアミド塩または１−メチル−３−アセチルピリジニウム塩である、請求項１〜３のいずれか一項に記載の製剤。
- 経口投与のための形態である、請求項１〜５のいずれか一項に記載の製剤。
- 吸入により気道へ投与するための形態である、請求項１〜６のいずれか一項に記載の製剤。
- プロスタサイクリンＰＧＩ ２ の産生不足が、年齢に関連するものである、請求項１〜７のいずれか一項に記載の製剤。
- 胃腸粘膜を保護するためにプロスタサイクリンＰＧＩ ２ レベルを高めるためのものである、請求項１〜７のいずれか一項に記載の製剤。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PLP-364348 | 2004-01-12 | ||
| PL04364348A PL364348A1 (en) | 2004-01-12 | 2004-01-12 | Application of quaternary pyridine salts as vessel protection agent |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006548308A Division JP5052138B2 (ja) | 2004-01-12 | 2005-01-07 | 四級ピリジニウム塩の血管保護剤としての使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012072150A JP2012072150A (ja) | 2012-04-12 |
| JP2012072150A5 true JP2012072150A5 (ja) | 2013-03-07 |
| JP5597179B2 JP5597179B2 (ja) | 2014-10-01 |
Family
ID=34793495
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006548308A Active JP5052138B2 (ja) | 2004-01-12 | 2005-01-07 | 四級ピリジニウム塩の血管保護剤としての使用 |
| JP2011233155A Active JP5597179B2 (ja) | 2004-01-12 | 2011-10-24 | 四級ピリジニウム塩の血管保護剤としての使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006548308A Active JP5052138B2 (ja) | 2004-01-12 | 2005-01-07 | 四級ピリジニウム塩の血管保護剤としての使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US7935717B2 (ja) |
| EP (2) | EP2279738A1 (ja) |
| JP (2) | JP5052138B2 (ja) |
| CN (1) | CN1905875B (ja) |
| AT (1) | ATE524179T1 (ja) |
| AU (1) | AU2005205066C1 (ja) |
| CA (1) | CA2547234C (ja) |
| DK (1) | DK1713480T3 (ja) |
| ES (1) | ES2372756T3 (ja) |
| PL (2) | PL364348A1 (ja) |
| PT (1) | PT1713480E (ja) |
| RU (1) | RU2366420C2 (ja) |
| WO (1) | WO2005067927A2 (ja) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL364348A1 (en) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
| PL1919466T3 (pl) * | 2005-07-11 | 2012-05-31 | Cortria Corp | Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu |
| CA2629913A1 (en) * | 2005-12-09 | 2007-06-14 | Cerecon Ag | Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| JP2009529057A (ja) | 2006-03-08 | 2009-08-13 | コートリア・コーポレーシヨン | Ｃｏｘ−関連胃損傷を予防するための非−選択的ｃｏｘ阻害剤との組み合わせ療法 |
| EP2079471A2 (en) * | 2006-10-18 | 2009-07-22 | Dermena | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
| PL381862A1 (pl) * | 2007-02-28 | 2008-09-01 | Trigendo Spółka Z Ograniczoną Odpowiedzialnością | Zastosowanie związków pirydyniowych i sposób leczenia |
| EP2203055A4 (en) * | 2007-09-28 | 2010-12-15 | 1-METHYL NICOTINAMIDE AND DERIVATIVES FOR THE TREATMENT OF GASTRIC INJURY | |
| PL2211857T3 (pl) * | 2007-10-12 | 2012-11-30 | Politechnika Lodzka | Zastosowanie czwartorzędowych soli pirydyniowych do radioprotekcji |
| EP2211858B1 (en) | 2007-10-12 | 2015-03-25 | Politechnika Lodzka | Use of quaternary pyridinium salts for inhibiting cancer metastases |
| US8304439B1 (en) | 2007-10-12 | 2012-11-06 | Politechnika Lodzka | Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage |
| MX2010012106A (es) * | 2008-05-06 | 2011-03-21 | Cortria Corp | Analogos de 1-metilnicotinamida. |
| PL2307380T3 (pl) * | 2008-07-01 | 2013-01-31 | Univ Jagiellonski | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego |
| MY163762A (en) * | 2008-07-23 | 2017-10-31 | Toray Industries | Therapeutic agent for chronic renal failure |
| EP2186419A1 (en) * | 2008-11-13 | 2010-05-19 | Tchibo GmbH | NMP-containing extract, a method of its production and uses thereof |
| KR101309576B1 (ko) * | 2011-05-25 | 2013-09-17 | 연세대학교 산학협력단 | 대사물질을 이용한 심부전 바이오마커 |
| PL226999B1 (pl) * | 2013-06-11 | 2017-10-31 | Univ Jagielloński | Azotan (III) 3 -karbamoilo -1-metylopirydyniowy, sposób jego otrzymywania izastosowanie |
| CN105771005A (zh) * | 2016-03-24 | 2016-07-20 | 乐普（北京）医疗器械股份有限公司 | 一种抗风湿性血管狭窄药物支架及其制备方法和应用 |
| JP2019521160A (ja) * | 2016-07-18 | 2019-07-25 | ファルメナ エスエー | Ｃ反応性タンパク質関連疾患の治療のための１−メチルニコチンアミド |
| WO2018015862A1 (en) | 2016-07-18 | 2018-01-25 | Pharmena S.A. | 1-methylnicotinamide salts for use in raising the blood levels of adiponectin |
| AU2018307807B2 (en) * | 2017-07-27 | 2024-05-02 | Eastern Michigan University | Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use |
| PL238932B1 (pl) * | 2017-12-31 | 2021-10-18 | Univ Jagiellonski | Pochodne soli pirydyniowych oraz ich zastosowanie |
| US10864207B2 (en) * | 2019-01-02 | 2020-12-15 | Celagenex Research (India) Pvt. Ltd. | Method of treating endothelial dysfunction |
| WO2021205341A1 (en) | 2020-04-07 | 2021-10-14 | Pharmena S.A. | 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB675430A (en) | 1949-07-12 | 1952-07-09 | Cilag Ltd | Novel quaternary nicotinic acid amide derivatives and production thereof |
| DE840698C (de) | 1949-07-12 | 1952-06-05 | Cilag Aktiengesellschaft | Verfahren zur herstellung neuer derivate des nicotinsaureamids |
| US5260305A (en) | 1988-12-12 | 1993-11-09 | E. R. Squibb & Sons, Inc. | Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination |
| US6406715B1 (en) | 1993-09-20 | 2002-06-18 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
| US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
| US20060263428A1 (en) | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
| US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
| US20030161880A1 (en) | 1997-03-06 | 2003-08-28 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US6469035B1 (en) | 1997-07-31 | 2002-10-22 | Eugenio A. Cefali | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
| US20010006644A1 (en) | 1997-07-31 | 2001-07-05 | David J. Bova | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
| IE970731A1 (en) | 1997-10-07 | 2000-10-04 | Fuisz Internat Ltd | Product and method for the treatment of hyperlipidemia |
| PL190755B1 (pl) * | 1999-01-07 | 2006-01-31 | Pharmena Sp Z Oo | Preparat do leczenia i profilaktyki chorób skóry |
| JP2002255846A (ja) * | 2001-02-26 | 2002-09-11 | Sunstar Inc | 経口組成物 |
| CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| US20050130990A1 (en) | 2001-03-23 | 2005-06-16 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US7153870B2 (en) * | 2003-07-25 | 2006-12-26 | Pfizer Inc. | Nicotinamide derivatives useful as PDE4 inhibitors |
| PL364348A1 (en) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
| WO2006052569A1 (en) | 2004-11-05 | 2006-05-18 | Arena Pharmaceuticals, Inc. | Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| PL1919466T3 (pl) | 2005-07-11 | 2012-05-31 | Cortria Corp | Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu |
| EP2079471A2 (en) * | 2006-10-18 | 2009-07-22 | Dermena | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
| PL381862A1 (pl) | 2007-02-28 | 2008-09-01 | Trigendo Spółka Z Ograniczoną Odpowiedzialnością | Zastosowanie związków pirydyniowych i sposób leczenia |
-
2004
- 2004-01-12 PL PL04364348A patent/PL364348A1/xx unknown
-
2005
- 2005-01-07 CN CN2005800017124A patent/CN1905875B/zh active Active
- 2005-01-07 US US10/585,892 patent/US7935717B2/en active Active
- 2005-01-07 DK DK05726215.6T patent/DK1713480T3/da active
- 2005-01-07 PT PT05726215T patent/PT1713480E/pt unknown
- 2005-01-07 AU AU2005205066A patent/AU2005205066C1/en active Active
- 2005-01-07 RU RU2006129299/15A patent/RU2366420C2/ru active
- 2005-01-07 EP EP10180501A patent/EP2279738A1/en not_active Withdrawn
- 2005-01-07 AT AT05726215T patent/ATE524179T1/de active
- 2005-01-07 EP EP05726215A patent/EP1713480B1/en active Active
- 2005-01-07 PL PL05726215T patent/PL1713480T3/pl unknown
- 2005-01-07 JP JP2006548308A patent/JP5052138B2/ja active Active
- 2005-01-07 WO PCT/EP2005/050057 patent/WO2005067927A2/en active Application Filing
- 2005-01-07 ES ES05726215T patent/ES2372756T3/es active Active
- 2005-01-07 CA CA2547234A patent/CA2547234C/en active Active
-
2010
- 2010-01-11 US US12/685,377 patent/US8124631B2/en active Active
-
2011
- 2011-04-08 US US13/083,106 patent/US8969391B2/en active Active
- 2011-10-24 JP JP2011233155A patent/JP5597179B2/ja active Active
-
2014
- 2014-06-12 US US14/303,054 patent/US9119844B2/en active Active
-
2015
- 2015-01-16 US US14/598,888 patent/US9333196B2/en active Active
-
2016
- 2016-05-04 US US15/146,485 patent/US9675601B2/en active Active